Home > Publications database > Soft drink and juice consumption and renal cell carcinoma incidence and mortality in the European Prospective Investigation into Cancer and Nutrition. > print |
001 | 168383 | ||
005 | 20240229133607.0 | ||
024 | 7 | _ | |a 10.1158/1055-9965.EPI-20-1726 |2 doi |
024 | 7 | _ | |a pmid:33849969 |2 pmid |
024 | 7 | _ | |a 1055-9965 |2 ISSN |
024 | 7 | _ | |a 1538-7755 |2 ISSN |
024 | 7 | _ | |a altmetric:103884168 |2 altmetric |
037 | _ | _ | |a DKFZ-2021-00870 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Heath, Alicia K |0 0000-0001-6517-1300 |b 0 |
245 | _ | _ | |a Soft drink and juice consumption and renal cell carcinoma incidence and mortality in the European Prospective Investigation into Cancer and Nutrition. |
260 | _ | _ | |a Philadelphia, Pa. |c 2021 |b AACR |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1625058669_23645 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2021 Jun;30(6):1270-1274 |
520 | _ | _ | |a Renal cell carcinoma (RCC) accounts for more than 80% of kidney cancers in adults and obesity is a known risk factor. Regular consumption of sweetened beverages has been linked to obesity and several chronic diseases including some types of cancer. It is uncertain whether soft drink and juice consumption is associated with risk of RCC. We investigated the associations of soft drink and juice consumption with RCC incidence and mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC).389,220 EPIC participants with median age 52 years at recruitment (1991-2000) were included. Cox regression yielded adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for RCC incidence and mortality in relation to intakes of juices and total, sugar-sweetened, and artificially-sweetened soft drinks.888 incident RCCs and 356 RCC deaths were identified. In models including adjustment for body mass index and energy intake, there was no higher risk of incident RCC associated with consumption of juices (HR per 100 g/day increment=1.03, 95% CI 0.97-1.09), total soft drinks (HR=1.01, 0.98-1.05), sugar-sweetened soft drinks (HR=0.99, 0.94-1.05), or artificially-sweetened soft drinks (HR=1.02, 0.96-1.08). In these fully-adjusted models, none of the beverages were associated with RCC mortality (HR, 95% CI per 100 g/day increment 1.06, 0.97-1.16; 1.03, 0.98-1.09; 0.97, 0.89-1.07; and 1.06, 0.99-1.14, respectively).Consumption of juices or soft drinks was not associated with RCC incidence or mortality after adjusting for obesity.Soft drink and juice intakes are unlikely to play an independent role in RCC development or mortality. |
536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |x 0 |f POF IV |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de |
700 | 1 | _ | |a Clasen, Joanna L |0 0000-0003-4231-5740 |b 1 |
700 | 1 | _ | |a Jayanth, Nick P |0 0000-0002-6906-4219 |b 2 |
700 | 1 | _ | |a Jenab, Mazda |b 3 |
700 | 1 | _ | |a Tjonneland, Anne |0 0000-0003-4385-2097 |b 4 |
700 | 1 | _ | |a Petersen, Kristina E N |b 5 |
700 | 1 | _ | |a Overvad, Kim |b 6 |
700 | 1 | _ | |a Srour, Bernard |0 P:(DE-He78)0644671d309776d45e0fc705d1156cac |b 7 |u dkfz |
700 | 1 | _ | |a Katzke, Verena |0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |b 8 |u dkfz |
700 | 1 | _ | |a Bergmann, Manuela M |0 0000-0001-5064-227X |b 9 |
700 | 1 | _ | |a Schulze, Matthias B |0 0000-0002-0830-5277 |b 10 |
700 | 1 | _ | |a Masala, Giovanna |0 0000-0002-5758-9069 |b 11 |
700 | 1 | _ | |a Krogh, Vittorio |0 0000-0003-0122-8624 |b 12 |
700 | 1 | _ | |a Tumino, Rosario |0 0000-0003-2666-414X |b 13 |
700 | 1 | _ | |a Catalano, Alberto |0 0000-0003-2597-2060 |b 14 |
700 | 1 | _ | |a Pasanisi, Fabrizio |b 15 |
700 | 1 | _ | |a Brustad, Magritt |b 16 |
700 | 1 | _ | |a Olsen, Karina Standahl |0 0000-0002-2539-4603 |b 17 |
700 | 1 | _ | |a Skeie, Guri |0 0000-0003-2476-4251 |b 18 |
700 | 1 | _ | |a Lujan-Barroso, Leila |0 0000-0001-6224-1764 |b 19 |
700 | 1 | _ | |a Rodríguez-Barranco, Miguel |0 0000-0002-9972-9779 |b 20 |
700 | 1 | _ | |a Amiano, Pilar |b 21 |
700 | 1 | _ | |a Santiuste, Carmen |b 22 |
700 | 1 | _ | |a Barricarte Gurrea, Aurelio |b 23 |
700 | 1 | _ | |a Axelson, Håkan |b 24 |
700 | 1 | _ | |a Ramne, Stina |0 0000-0003-1291-4494 |b 25 |
700 | 1 | _ | |a Ljungberg, Borje |0 0000-0002-4121-3753 |b 26 |
700 | 1 | _ | |a Watts, Eleanor L |0 0000-0001-9229-2589 |b 27 |
700 | 1 | _ | |a Huybrechts, Inge |0 0000-0003-3838-855X |b 28 |
700 | 1 | _ | |a Weiderpass, Elisabete |0 0000-0003-2237-0128 |b 29 |
700 | 1 | _ | |a Riboli, Elio |b 30 |
700 | 1 | _ | |a Muller, David C |b 31 |
773 | _ | _ | |a 10.1158/1055-9965.EPI-20-1726 |g p. cebp.1726.2020 - |0 PERI:(DE-600)2036781-8 |n 6 |p 1270-1274 |t Cancer epidemiology, biomarkers & prevention |v 30 |y 2021 |x 1538-7755 |
909 | C | O | |o oai:inrepo02.dkfz.de:168383 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)0644671d309776d45e0fc705d1156cac |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |
913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Cancer risk factors and prevention |x 0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
914 | 1 | _ | |y 2021 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-02-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-02-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-02-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2021-02-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-02-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2021-02-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-02 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-02-02 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CANCER EPIDEM BIOMAR : 2019 |d 2021-02-02 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2021-02-02 |
920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C020-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|